# Monopar Therapeutics (MNPR) - Q1 2026 earnings

Reported May 14, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | - | Not available |
| EPS | $-0.46 | $-1.06 |

Earnings filing reader: [8-K 0001437749-26-016981](https://www.opencapital.sh/filings/0001437749-26-016981)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001437749-26-016981.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1645469/000143774926016981/0001437749-26-016981-index.htm)
Periodic report: 10-K/A - https://www.sec.gov/Archives/edgar/data/1645469/000143774926010841/0001437749-26-010841-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/mnpr/earnings/q1-2026